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Human hookworm infection is a major cause of anemia and malnutrition in the
developing world. In an effort to control hookworm infection, the Human
Hookworm Vaccine Initiative has identified candidate vaccine antigens from the
infective larval stage (L3) of the parasite, including a family of pathogenesis-
related-1 (PR-1) proteins known as the ancylostoma-secreted proteins (ASPs).
The functions of the ASPs are unknown. In addition, it is unclear why some
ASPs have one while others have multiple PR-1 domains. There are no known
structures of a multi-domain ASP and in an effort to remedy this situation,
recombinant Na-ASP-1 has been expressed, purified and crystallized. Na-ASP-1
is a 406-amino-acid multi-domain ASP from the prevalent human hookworm
parasite Necator americanus. Useful X-ray data to 2.2 A˚ have been collected
from a crystal that belongs to the monoclinic space group P21 with unit-cell
parameters a = 67.7, b = 74.27, c = 84.60 A˚,  = 112.12. An initial molecular-
replacement solution has been obtained with one monomer in the asymmetric
unit.
1. Introduction
Hookworms are one of the most predominant parasites of humans:
they cause morbidity in almost one billion people worldwide (Hotez
et al., 2004). Hookworm disease is prevalent wherever rural poverty
occurs, including the tropics and subtropics, placing a serious burden
on those who can least afford it. The nematodes Necator americanus
and Ancylostoma duodenale produce injury through intestinal
hemorrhage as they feed on host hemoglobin, resulting in blood loss,
protein malnutrition, anemia and other complications. Current
control methods for hookworm infection include barrier foot
protection, sanitation (construction of pit latrines) and anthelminthic
chemotherapy primarily aimed at deworming school-age children.
The foot barrier protection is an ineffective control method because
Ancylostoma is orally infective and Necator infects through the upper
and lower extremeties (Bethony et al., 2002). Anthelminthic chemo-
therapy using benzimidazoles is only a temporary solution, as rapid
reinfection occurs within four to six months (World Health Organi-
zation, 2002).
As an alternative or complementary approach to hookworm
control, an international effort has been initiated to develop an anti-
hookworm vaccine aimed at reducing worm burdens and intensity
(Hotez et al., 2003). The selection of antigens for hookworm vaccine
development is based partly on the early observation that the
infective stages of the parasite, the third-stage larvae (L3), are
immunogenic (Miller, 1971) and that radiation-attenuated living L3
have been successfully used as a veterinary vaccine for canine
hookworm infection in the late 1970s (Miller, 1978). A major goal of
vaccine development for humans is to reproduce the effect of live
attenuated L3 vaccines by substituting with L3-derived antigens in
recombinant form (Hotez et al., 2003). It was subsequently deter-
mined that there are two major antigens secreted by L3 upon host
entry: ancylostoma-secreted protein-1 (ASP-1) and ASP-2. ASPs are
nematode-specific proteins that belong to the pathogenesis-related
(PR) protein superfamily. PR proteins were initially isolated from
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plants and their name is related to the elevated expression of these
proteins upon injuries inflicted by pathogens or by other stress factors
(Van Loon & Van Strien, 1999).
ASPs are members of the PR-1 subfamily, which includes the
mammalian cysteine-rich secreted protein (CRISP) family as well as a
diversity of proteins from the animal, plant and fungal kingdoms.
Specific members include mammalian testis-specific protein (Kasa-
hara et al., 1989), human brain tumor protein GliPR (Mochca-
Morales et al., 1990) and antigen 5 from Vespula vilgaris venom (Lu et
al., 1993). While the function of this subfamily is unknown, its
members are characterized by a highly conserved cysteine-rich
domain of about 15–16 kDa molecular weight and have been impli-
cated in conditions requiring cellular defense or proliferation such as
plant pathogenesis and brain-tumor growth. Two types of ASP have
been isolated from larval nematodes and they either possess a single
PR-1 domain (Na-ASP-2) or two PR-1 domains (Na-ASP-1).
Na-ASP-1 is a 406-amino-acid protein that has a molecular weight of
43.9 kDa and is approximately twice the size of the 197-amino-acid
21.3 kDa Na-ASP-2.
There are no known structures of multi-domain PR-1 proteins and
only three structures of single-domain PR-1 proteins have been
reported. The three reported structures are the X-ray structure of
Ves v 5 (PDB code 1qnx; Henriksen et al., 2001), the NMR structure
of p14a, a PR-1 protein from tomato (PDB code 1cfe; Fernandez et
al., 1997), and the high-resolution (1.68 A˚) structure of Na-ASP-2
(PDB code 1u53; Asojo et al., 2005), in which the protein exists in the
form of a crystallographic dimer. The dimeric nature of Na-ASP-2
was also confirmed by SEC-MALS analysis (Asojo et al., 2005).
The sequence identity between Na-ASP-1 and Ves v 5, p14a and
Na-ASP-2 are 19, 17 and 27%, respectively. Despite limited sequence
identity, there is a significant conservation and alignment within the
conserved PR-1 domain (Fig. 1). In order to clarify the structural
basis of multi-domain PR-1 proteins and their associated antigenic
properties, we have expressed, purified and crystallized recombinant
crystallization communications
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Figure 1
CLUSTALW alignment of PR-1 proteins of known structure with Na-ASP-1. Two monomers of the single-domain PR-1 proteins Na-ASP-2, Ves5 and P14a are aligned with
a monomer of Na-ASP-1. Na-ASP-2, L3 ASP from N. americanus (AY288089); Ves5, antigen Ves v 5 from Vespula vilgaris (Q05110); P14a is from cherry tomato (P04284).
PUBMED protein ID codes are shown in parentheses (http://www.pubmed.org). The PDB codes are 1u53, 1qnx and 1cfe for Na-ASP-2, Ves5 and P14a, respectively. Amino
acids are colored as follows: red for small and hydrophobic amino acids (AVFPMILW), blue for acidic amino acids (DE), magenta for basic amino acids (RHK) and green for
hydroxyl, amine and basic (STYHCNGQ). ‘*’ indicate sites in all aligned sequences with identical residues, while ‘.’ and ‘:’ indicate conservatively mutated positions (there is
higher conservation for the latter than the former).
Na-ASP-1. Here, we present our preliminary crystallographic
analysis.
2. Expression and purification of Na-ASP-1
2.1. Cloning
A cDNA library of infective third-stage larvae (L3) of N. amer-
icanus was constructed as described previously (Hawdon et al., 1996;
Zhan et al., 1999). The entire coding sequence minus the N-terminal
signal peptides of Na-asp-1 was PCR amplified from the first-strand
cDNA of N. americanus L3 with Na-asp-1 gene-specific primers: 50-
CTCTCGAGAAGAGATCTCCAGCAAGAGACAGCTTC-30 and
50-GGGGTACCTTAAGGAGCGCTGCACAAGCC-30. The primers
introduced XhoI and KpnI sites (bold) on the 50 and 30 ends of the
gene, respectively. The PCR product was subcloned into the
expression vector pPICZA partially digested with XhoI and KpnI
restriction enzymes. The Na-asp-1 gene was fused to the pre-pro
leader sequence of Saccharomyces cerevisiae -mating factor under
the control of the AOX1 promoter. The construct sequence was
confirmed by sequencing the insert. pPICZNa-asp-1 was linearized
before transforming into Pichia pastoris KM71H (muts: methanol
utilization slow). Transformants were selected on YPD plates
containing Zeocin (100 mg l1).
2.2. Fermentation
A single colony was grown in BMGY medium (1% yeast extract,
2% peptone, 0.1M potassium phosphate buffer pH 6.0, 1.3% yeast
nitrogen base and 1.2% glycerol) in shaker flasks. The culture was
grown for approximately 48 h to an optical density of 4–5; 150 ml of
the seed culture was aseptically transferred to 2 l fermentation
medium. Fermentations were performed in a 5 l Bioflo III/3000
stirred-tank fermentor (New Brunswick Scientific, Edison, GA,
USA) with a 2 l starting volume interfaced with a computer using
Biocommand 32 software (New Brunswick Scientific) for data
acquisition and control. Methanol was fed into the fermentor using a
closed-loop control system with a methanol feed pump (Model 101
U/R, Watson-Marlow, UK) and a balance (Model PG 12001-S,
Mettler Toledo, Switzerland) for weighing the methanol bottle
interfaced with the computer using Biocommand 32 software. The
methanol concentration in the off-gas was analyzed with a methanol
concentration monitor and controller (Model MC-168, PTI Instru-
ments, Kathleen, GA, USA). Fermentations were performed at
303 K. The pH during growth (glycerol batch and fed-batch phase)
was maintained at 5.0 and then ramped up to 6.0 over a 2 h period
starting from induction with methanol (beginning of the transition
phase). Saturated aqueous ammonium hydroxide was used to control
the pH at 6.0 until the end of fermentation. FM22 medium (Stratton
et al., 1998) was employed for growth and recombinant protein
production.
The fermentation procedure was divided into three phases: batch
phase, fed-batch phase and induction phase. Glycerol (40 g l1) was
also added during the batch phase, which lasted 20–24 h after
inoculation. The fed-batch phase began with the addition of 50%
glycerol (20 g l1) and lasted until the wet cell weight was about
300 g l1. The induction phase began with the addition of methanol
(1 ml l1), upon which the glycerol feed was slowly ramped down.
Once the cells were adapted to methanol, a methanol feed containing
2 ml l1 PTM1 salts was started. The methanol sensor was used to
control the methanol concentration, maintaining about 1 g l1
throughout the induction period, which lasted 60 h. 20% peptone was
also added to reduce the proteolytic activity in fermentors.
2.3. Purification
The fermentation broth was harvested at 6000g for 20 min at
277 K. PMSF and EDTA were immediately added to final concen-
trations of 2 and 5 mM, respectively. The broth was diafiltered into
50 mM Tris, 5 mM EDTA pH 8.3 using a 3 kDa regenerated cellulose
membrane at 206 kPa at 277–285 K. The retentate was loaded onto a
1 l Q-Sepharose FF column. After the column had been equili-
brated with 50 mM Tris, 5 mM EDTA pH 8.3, the diafiltered ASP-1
was loaded onto the column. The product was collected in the Q
column flowthrough. The product from the Q column flowthrough
was concentrated from a volume of 3 l down to 10 ml. A bench-top
ultrafiltration unit (regenerated cellulose membrane, 10 kDa
molecular-weight cutoff) was used for the initial concentration. An
Amicon Stirred Cell (Omega membrane, 5 kDa molecular-weight
cutoff) was then used to reach the required final volume and
concentration. Size-exclusion chromatography using Sephacryl S-100
High Resolution resin was used as the final polishing step. The
product was eluted with PBS buffer pH 7.2. Purity was confirmed by
SDS–PAGE analysis and prior to crystallization, protein was desalted
and concentrated with a Microcon (Millipore, 30 kDa molecular-
weight cutoff) concentrator.
3. Crystallization
Initial crystallization screens were carried out on samples of
Na-ASP-1 using sparse-matrix screens from Emerald Biostructures
and Hampton Research, including Wizard Screens, Crystal Screens I
and II and all Cryo Screens. These experiments were carried out at
three different temperatures: 293, 285 and 277 K. Similar behavior
was observed regardless of growth temperature. Crystals were grown
by vapor diffusion in hanging drops which were equilibrated against
1 ml crystallization solution. Drops were prepared by mixing 2 ml of
protein solution with an equal volume of crystallization solution. All
protein solutions for crystallization experiments consisted of
15 mg ml1 Na-ASP-1 in 10 mM Tris–HCl pH 7.5. The initial protein
concentration was confirmed spectrophotometrically prior to setting
up crystallization experiments. Several conditions from the Cryo
Screens yielded promising leads and gave small crystals or showers of
crystals. These conditions were characterized by a high concentration
[between 20 and 40%(w/v)] of polyethylene glycol (6000 or 8000) and
a low concentration of buffer (less than 200 mM). The pH did not
seem to be important to nucleation, as plate-like crystals were
obtained at pH values ranging from 5.1 (citrate) to 9.3 (CHES). Large
plate-like crystals were obtained upon optimization of the crystal-
crystallization communications
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Figure 2
Crystals of Na-ASP-1 are thin flat plates of less than 0.05 mm on the smallest face.
lization conditions. Despite the relative ease of crystal growth, crystal
cracking and degradation after four weeks (at 298 and 277 K) has
been observed. Consequently, the diffraction patterns from older
crystals were significantly poorer than those from fresh crystals. The
protein solution degraded over time and samples that initially crys-
tallized would not crystallize after three weeks at 277 K.
The largest crystals were obtained overnight by vapor diffusion
from hanging drops containing a mixture of 3 ml (7.5 mg ml1)
protein and 1.5 ml reservoir solution, with a reservoir containing
21%(w/v) PEG 6000 and 200 mM sodium citrate pH 6.0. Similar
crystals were also obtained from a reservoir solution containing
30%(w/v) PEG 8000 and 100 mM CHES pH 9.3. These plate-like
crystals grew to dimensions of 0.3  0.5  0.05 mm on the smallest
face (Fig. 2) and degraded rapidly over a four-week period.
4. Diffraction experiments and structure determination
Since crystals grew in solutions that contained adequate cryo-
protectant, the crystals were flash-cooled in a stream of N2 gas at
113 K prior to collecting diffraction data on a MAR 345 detector
(MAR Research). The X-ray source was a Rigaku RU-200 rotating-
anode generator operating at 50 kV and 100 mA, with a double
focusing-mirror system. A complete data set was collected from a
single crystal using a crystal-to-detector distance of 150 mm and
exposure times of 20 min for 1.0 oscillations. All X-ray diffraction
data sets were processed using the programs DENZO (Otwinowski,
1993a) and SCALEPACK (Otwinowski, 1993b). Crystallographic
data is shown in Table 1. With the volume of the unit cell (P2 or P21)
being 394 122 A˚3 and the solvent content being between 40 and 80%
of the unit-cell volume (with respective Matthews coefficients
between 2.1 and 5.4 A˚3 Da1), the asymmetric unit of those crystals
was expected to contain either a monomer or dimer of Na-ASP-1.
These molecular packings would correspond to Matthews coefficients
of 4.48 A˚3 Da1 (72.6% solvent) and 2.24 A˚3 Da1 (45.1% solvent)
for a monomer and dimer in the asymmetric unit, respectively.
Using residues 12–180 of the full structure of Na-ASP-2 as the
search model and the program AMoRe (Navaza, 1994), a satisfying
molecular-replacement solution was found in space group P21 but not
in P2. The correlation coefficient and initial R factors were 32.1 and
47.8% for a monomer of Na-ASP-1 in the asymmetric unit. The
resulting packing is reasonable and negates the possibility of a
dimeric form of Na-ASP-1. Model building and refinement are in
progress.
The Human Hookworm Vaccine Initiative is supported by a grant
from The Bill and Melinda Gates Foundation awarded to the Sabin
Vaccine Institute and George Washington University Medical Center.
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Table 1
Data-collection and reduction statistics.
Values in parentheses are for the highest resolution shell.
Space group P21
Unit-cell parameters (A˚, ) a = 67.7, b = 74.27,
c = 84.60,  = 112.12
Resolution limits (A˚) 50–2.18 (2.18–2.26)
hI/(I)i 13.5 (2.68)
No. of reflections 324988
No. of unique reflections 39175
Redundancy 8.3 (7.4)
Rmerge† (%) 10.6 (49.7)
Completeness (%) 96.1 (93.9)
† Rmerge =
P jI  hIij=P I, where I is the observed intensity and hIi is the average
intensity obtained from multiple observations of symmetry-related reflections after
rejections.
